those not treated 12 days. The results are statistically significant (p < 0.001).
In addition, more players in the control group (12 of 51; 24%) were absent from games longer than 3 weeks, compared to the intervention group (2 of 29; 7%). These results are also statistically significant (p = 0.028).
None of the participants who were treated with PolarCap® System indicated that they would refuse treatment if they experienced a new concussion.
These findings are important considering that curtailed absence after brain injury due to treatment with PolarCap® System generates financial benefits for athletes, sports teams, and insurance companies. Above all, the social and health benefits consist of the potential limited neurological damage as a result of treatment with PolarCap® System.
The study has generated positive feedback from medical teams as well as from athletes. Overall, the results show that early cooling as an acute treatment method for concussions in this study has had positive effects.